2218 ⎘
Animals characterised by purpose; Animal model, e.g. for test or diseases Animal model for proliferative diseases
Compositions and methods for the treatment of cancer
#602Tie-2 driven overexpression of calreticulin as an inducer of non-small cell carcinoma of lung
#603Tumor models employing green fluorescent protein
#604Screening Assay and Treatment
#605Genetic characterization and prognostic significance of cancer stem cells in cancer
#606Recurrent gene fusions in prostate cancer
#607Hybrid cells
#608USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA
#609Methods of using flt3-ligand in the treatment of cancer
#610Integrated in vivo animal experimentation systems
#611Transgenic animals and methods of monitoring hedgehog responding cells
#612COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#613VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES
#614Knockout mouse for the tumor suppressor gene ANX7
#615Zebrafish models of acute myelogenous leukemia
#616Targeting of SALL4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (MDS)
#617Expression of cyclin G1 in tumors
#618Reconstituted human breast tumor model
#619TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE
#620Protein fragment complementation assays for the detection of biological or drug interactions
#621Mutation in the rat adenomatous polyposis coli gene within the human mutation hotspot region
#622Oncohumouse
#623Genetically determined mouse model of resistance to transplantable cancers
#624Vectors, mutant viruses and methods for generating mutant viruses
#625Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
#626Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin
#627Ion channel
#628Mutant herpes simplex viruses comprising nucleic acid encoding a nitroreductase
#629Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases
#630Cysteine engineered antibodies and conjugates
#631C/EBPalpha gene targeting constructs and uses thereof
#632Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#633Methods of obtaining neural stem cells
#634Inhibitor of differentiation knockout mammals and methods of use thereof
#635Transgenic mammal with constitutive, tissue-specific cytokine expression and use as a cancer model
#636Transplantable tumor model
#637Methods for producing microRNAs
#638Gp131: methods and compositions for treating cancer
#639Method for identifying modulators of the dioxin/aryl hydrocarbon receptor (AHR)
#640Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
#641Methods and compositions for in vivo inflammation monitoring
#642Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin
#643Uses for Eph receptor antagonists and agonists
#644Transgenic non-human Act1-deficient mammals and uses thereof
#645Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15
#646Methods and compositions for detecting cancers
#647Endothelial cell specific antibodies and uses thereof
#648Defective sindbis viral vectors
#649ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE
#650Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferase
#651Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
#652Mouse models of human prostate cancer
#653Model for studying the role of genes in tumor resistance to chemotherapy
#654Genetic screen in drosophila for metastatic behavior
#655Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
#656Mediators of epithelial adhesion and their role in cancer and skin disorders
#657Methods for immunotherapy of cancer
#658Method of determining xenograft responses
#659Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
#660Gab2 (p97) gene and methods of use thereof
#661Sporadic tumor mouse model for drug discovery
#662Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#663Modulation of angiogenesis
#664Directed complementation
#665Transcription amplification system for molecular imaging
#666Directed complementation
#667Transgenic mice expressing human CD20 and/or CD16
#668Methods of treating and detecting cancer using viruses
#669TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1
#670Animal model of ligand activated HER2 expressing tumors
#671Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#672Target validation assay
#673Method for preparing anti-MIF antibodies
#674Anti-IL-6 antibodies, compositions, methods and uses
#675Transgenic mice expressing human cd20
#676Tumor model with chromosomal rearrangement and uses thereof
#677Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancer
#678Reconstituted human breast tumor model
#679High throughput screening methods for anti-metastatic compounds
#680Induction of apoptosis in toll-like receptor expressing tumor cells
#681Methods and compositions for modulating and detecting WISP activity
#682Animal model for the fast identification of pharmaceutical active compounds in vivo
#683Transgenic non-human mammals as models for human pathologies of stem cell origin
#684Method of screening candidate drugs for the treatment of leukemia
#685Transgenic non-human mammals as models for human pathologies of stem cell origin
#686Transgenic non-human mammals as models for human pathologies of stem cell origin
#687Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit
#688Reconstituted human breast tumor model
#689Reconstituted human breast tumor model
#690Animal model for human lymphomas
#691Method to enhance delivery of glutathione and ATP levels in cells
#692Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene
#693Rors as modifiers of the p21 pathway and methods of use
#694Anti-cancer virus desensitization method
#695Gene reactivation by somatic hypermutation
#696Muir-Torre-like syndrome in Fhit deficient mice
#697Methods and compositions for cell activation
#698Fusion protein for inhibiting cervical cancer
#699Non-mammalian transgenic animal model for cellular proliferative diseases
#700Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#701Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#702Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#703Methods and compositions for identification of genomic sequences
#704Transgenically produced fusion proteins
#705Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
#706In vivo animal model of human leukemia
#707Screening assays and methods of tumor treatment
#708High throughput cancer pharmaceutical screening using drosophila
#709Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
#710Antisense composition and method for treating cancer
#711High throughput pharmaceutical screening using
#712Inductive switch
#713BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
#714Use of herpes vectors for tumor therapy
#715Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
#716HIF oligonucleotide decoy molecules
#717Tumor model
#718Tumor treating composition and methods
#719Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#720Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders
#721Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof
#722Expressed ligand-vascular intercellular signaling molecule
#723Polynucleotides encoding growth differentiation factor-8
#724Mouse models for studying and treating hepatocellular and gastrointestinal tumors
#725RhPV as a model for HPV-induced cancers
#726Transgenic animal model for the treatment of skin tumors
#727Animal model for the analysis of tumor metastasis
#728Knockout mouse for the tumor suppressor gene ANX7
#729Full-length prostate selective polynucleotides and polypeptides
#730Feline bronchioloalveolar lung carcinoma xenograft and cell line
#731Non-human transgenic mammals used as models for human pathologies originating from stem cells
#732Expressed ligand-vascular intercellular signaling molecule
#733Modulation of angiogenesis
#734C/EBPalpha gene targeting constructs and uses thereof
#735Animal models of retinal tumorigenesis
#736Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
#737GRP94-based compositions and methods of use thereof
#738Use of ephrins and related molecules to regulate cellular proliferation
#739LKB1 gene knockout animals
#740Rat highly sensitive to carcinogen
#741Modulation of angiogenesis
#742Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#743Transgenic animal model for cancer and stem cells
#744Genetically determined mouse model of resistance to transplantable cancers
#745Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth
#746ALK protein tyrosine kinase, cells and methods embodying and using same
#747Method of screening for compounds that modulate activity of a regulatory sequence of the β-2 subunit of a neuronal nicotinic acetylcholine receptor
#748Methods for modulating hematopoiesis and vascular growth
#749Gene delivery system and methods of use
#750Tools to detect, track and target cancer cells in vivo
#751PTP4A1 as a therapeutic target for fibrotic diseases and disorders including systemic sclerosis